<DOC>
	<DOCNO>NCT01895972</DOCNO>
	<brief_summary>The objective study demonstrate clinical safety latanoprostene bunod 0.024 % daily ( QD ) 1-year treatment period .</brief_summary>
	<brief_title>A Study Evaluating Long-Term Safety Latanoprostene Bunod Ophthalmic Solution 0.024 % , Japanese Subjects With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects must diagnosis open angle glaucoma ( OAG ) ( include normaltension glaucoma [ NTG ] , pigmentary pseudoexfoliative glaucoma ) , ocular hypertension ( OHT ) one eye . Subjects must meet follow IOP requirement Visit 3 ( Eligibility , Day 0 [ washout subject already treatment ] ) : mean/median IOP ≥15 mmHg ≤36 mmHg 10 AM least 1 eye ; IOP ≤36 mmHg eye . Subjects correct Decimal visual acuity ( VA ) BestCorrected Decimal Visual Acuity ( BCVA ) 0.5 good eye . Subjects unable discontinue contact lens use 15 minute follow instillation study drug study visit . Subjects unable discontinue eye drop medication artificial tear 15 minute prior 15 minute instillation study drug . Subjects central corneal thickness great 600 μm either eye . Subjects condition prevents reliable applanation tonometry either eye . Subjects advance glaucoma mean deviation ( MD ) &lt; −12 dB , history split fixation , field loss threaten fixation either eye . Subjects condition prevents clear visualization fundus . Subjects monocular ( fellow eye absent ) . Subjects aphakia either eye . Subjects active corneal disease either eye . Subjects severe dry eye either eye . Subjects history/diagnosis clinically significant progressive retinal disease either eye . Subjects narrow angle subject angle closure congenital , secondary glaucoma , subject history angle closure either eye . Subjects intraocular infection inflammation either eye within 3 month prior Visit 1 ( Screening ) . Subjects history ocular laser surgery either eye within 3 month ( 90 day ) prior Visit 1 ( Screening ) . Subjects history incisional ocular surgery severe trauma either eye within 3 month prior Visit 1 ( Screening ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>